Filing Details

Accession Number:
0000891293-15-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-26 18:50:09
Reporting Period:
2015-06-26
Filing Date:
2015-06-26
Accepted Time:
2015-06-26 18:50:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204264 W Jack Singer 3101 Western Ave.
Suite 600
Seattle WA 98121
Evp, Global Medical Affairs Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-26 400 $2.04 1,305,519 No 4 S Direct
Common Stock Disposition 2015-06-26 400 $2.05 1,305,119 No 4 S Direct
Common Stock Disposition 2015-06-26 1,200 $2.05 1,303,919 No 4 S Direct
Common Stock Disposition 2015-06-26 100 $2.06 1,303,819 No 4 S Direct
Common Stock Disposition 2015-06-26 3,500 $2.06 1,300,319 No 4 S Direct
Common Stock Disposition 2015-06-26 4,300 $2.07 1,296,019 No 4 S Direct
Common Stock Disposition 2015-06-26 2,200 $2.07 1,293,819 No 4 S Direct
Common Stock Disposition 2015-06-26 500 $2.08 1,293,319 No 4 S Direct
Common Stock Disposition 2015-06-26 200 $2.08 1,293,119 No 4 S Direct
Common Stock Disposition 2015-06-26 100 $2.09 1,293,019 No 4 S Direct
Common Stock Disposition 2015-06-26 1,200 $2.10 1,291,819 No 4 S Direct
Common Stock Disposition 2015-06-26 200 $2.11 1,291,619 No 4 S Direct
Common Stock Disposition 2015-06-26 700 $2.11 1,290,919 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale was effected pursuant to a Rule 10b5-1 trading plan.